国际皮肤性病学杂志    0  (): 308-310   ISSN: 2096-5540  CN: 32-1880/R   巨噬细胞衍生化学激活因子与皮肤病 俞星飞, 劳力民 浙江大学医学院附属二院皮肤科, 杭州310009 收稿日期 2005-01-27  修回日期 null  网络版发布日期 null 参考文献  [1] Zlotnik A, Yoshie O. Chemokines:a new classification system and their role in immunity. Immunity, 2000, 12:121-127. [2] Godiska R, Chantry D, Raport C J, et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes,monocyte-derived dendritic cells, and natural killer cells. J Exp Med, 1997, 185:1595-1604. [3] Imai T, Chantry D, Raport CJ, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem, 1998, 273:1764-1768. [4] Struyf S, Proost P, Sozzani S,et al. Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J Immunol, 1998, 161:2672-2675. [5] Pal R, Garzino-Demo A, Markham PD, et al. Inhibition of HIV-1infection by the beta-chemokine MDC. Science, 1997, 278:695-698. [6] Ghia P, Strola G, Granziero L, et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol, 2002, 32:1403-1413. [7] Campbell JJ, Pan J, Butcher EC. Cutting edge:developmental switches in chemokine responses during T cell maturation. J Immunol, 1999, 163:2353-2357. [8] Power CA, Clemetson JM, Clemetson K J, et al. Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine,1995, 7:479-482. [9] Suttitanamongkol S, Gear AR. ADP receptor antagonists inhibit platelet aggregation induced by the chemokines SDF-1, MDC and TARC. FEBS Lett, 2001, 490:84-87. [10] Kakinuma T, Nakamura K, Wakugawa M, et al. Serum macrophagederived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol, 2002, 127:270-273. [11] Galli G, Chantry D, Annunziato F, et al. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo:preferential association with the production of type 2 cytokines. Eur J Immunol, 2000, 30:204-210. [12] Furukawa H, Takahashi M, Nakamura K, et al. Effect of an antiallergic drug (Olopatadine hydrochloride)on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis. J Dermatol Sci, 2004, 36:165-172. [13] Horikawa T, Nakayama T, Hikita I, et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol, 2002,14:767-773. [14] Xiao T, Kagami S, Saeki H, et al. Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J Dermatol Sci, 2003, 31:111. [15] Grewe M, Bruijnzeel-Koomen CA, Schopf E, et al. A role for Th1and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today, 1998, 19:359-361. [16] Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines(TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci, 2004, 34:201. [17] Scala E, Pallotta S, Frezzolini A, et al. Cytokine and chemokine levels in systemic sclerosis:relationship with cutaneous and internal organ involvement. Clin Exp Immunol, 2004, 138:540-546. [18] Fujii H, Shimada Y, Hasegawa M, et al. Serum levels of a Th1chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC,are elevated in patients with systemic sclerosis. J Dermatol Sci,2004, 35:43-51. [19] Cota M, Mengozzi M, Vicenzi E,et al. Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine. Proc Natl Acad Sci U S A, 2000,97:9162-167. 通讯作者: